Cargando…
Could GLUT12 be a Potential Therapeutic Target in Cancer Treatment? A Preliminary Report
Background: Recent studies proposed GLUT12 to be a major glucose transporter involved in the glycolytic metabolism of cancer cells. Methods: GLUT12 expression was determined by immunohistochemistry in a selection of cancer cell lines and a tumour spheroid model. Results: GLUT12 expression was high i...
Autores principales: | Pujol-Gimenez, Jonai, de Heredia, Fátima Pérez, Idoate, Miguel Angel, Airley, Rachel, Lostao, María Pilar, Evans, Andrew Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280396/ https://www.ncbi.nlm.nih.gov/pubmed/25561978 http://dx.doi.org/10.7150/jca.10429 |
Ejemplares similares
-
Sodium-coupled glucose transport, the SLC5 family, and therapeutically relevant inhibitors: from molecular discovery to clinical application
por: Gyimesi, Gergely, et al.
Publicado: (2020) -
Glucose transporter-1 (GLUT-1): a potential marker of prognosis in rectal carcinoma?
por: Cooper, R, et al.
Publicado: (2003) -
A novel proton transfer mechanism in the SLC11 family of divalent metal ion transporters
por: Pujol-Giménez, Jonai, et al.
Publicado: (2017) -
Expression of the glucose transporters GLUT1, GLUT3, GLUT4 and GLUT12 in human cancer cells
por: Barron, Carly, et al.
Publicado: (2012) -
GLUT1 and TUBB4 in Glioblastoma Could be Efficacious Targets
por: Guda, Maheedhara R., et al.
Publicado: (2019)